Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.87Price to Book
VS
Market
Sector
Industry
History
$ 12.64Close
$ 5.31 - $ 12.64 52-Week Range
Ticker Information
Ticker
RGNXCompany Name
REGENXBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQREGENXBIO INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RGNX - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 213.68M | $ 399.06M | 1.87 |
| 3/31/2025 | $ 274.2M | $ 399.78M | 1.46 |
| 12/31/2024 | $ 259.65M | $ 328.06M | 1.26 |
| 9/30/2024 | $ 301.42M | $ 467.21M | 1.55 |
| 6/30/2024 | $ 348.27M | $ 657.82M | 1.89 |
| 3/31/2024 | $ 390.67M | $ 821.1M | 2.1 |
| 12/31/2023 | $ 311.74M | $ 889.44M | 2.85 |
| 9/30/2023 | $ 363.1M | $ 721.91M | 1.99 |
| 6/30/2023 | $ 405.86M | $ 830.85M | 2.05 |
| 3/31/2023 | $ 465.14M | $ 879.32M | 1.89 |
Key Performance Insights, Last 5 Years
- REGENXBIO INC's latest trailing twelve months (TTM) P/B stands at 2.8.
- Over the past 5 years, REGENXBIO INC's average P/B has been 2.21.
- The median P/B for REGENXBIO INC during this period was 1.94
- REGENXBIO INC reached its highest P/B over the past 5 years at 4.78.
- The lowest P/B recorded by REGENXBIO INC in the same timeframe 1.26
REGENXBIO INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for REGENXBIO INC is calculated as follows: Market Cap [ $ 1.16B ] / Equity [ $ 415.66M ]
(=) P/B [ 2.8 ] RGNX - Price to Book, Last 5 years
1.26
Minimum
Dec 31, 2024
4.78
Maximum
Dec 31, 2020
2.21
Average
1.94
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |